7 results on '"Zeng-Wu Yao"'
Search Results
2. Effect of Long Non-Coding RNA AOC4P on Gastrointestinal Stromal Tumor Cells [Retraction]
- Author
-
Lixin Jiang, Zeng-Wu Yao, Hui-Yuan Zhai, Li Cai, Quan Wang, Ye Feng, Meng-Lai Zhang, and Jinchen Hu
- Subjects
Oncology ,Cancer research ,Pharmacology (medical) ,Stromal tumor ,Biology ,Long non-coding RNA ,OncoTargets and Therapy - Abstract
Hu JC, Wang Q, Jiang LX, et al. Onco Targets Ther. 2018;11:6259–6269. The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised regarding the alleged duplication of images in Figure 3 and Figure 5. The authors responded to our queries but were unable to provide an explanation for the alleged image duplication and were unable to verify their original data and have therefore agreed to retract the article. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper
- Published
- 2021
3. Effect of long non-coding RNA AOC4P on gastrointestinal stromal tumor cells
- Author
-
Li Cai, Zeng-Wu Yao, Lixin Jiang, Ye Feng, Hui-Yuan Zhai, Meng-Lai Zhang, Jinchen Hu, and Quan Wang
- Subjects
0301 basic medicine ,Cell ,epithelial-mesenchymal transition ,Vimentin ,OncoTargets and Therapy ,gastrointestinal stromal tumors ,03 medical and health sciences ,0302 clinical medicine ,Western blot ,Annexin ,medicine ,Pharmacology (medical) ,Epithelial–mesenchymal transition ,Stromal tumor ,Original Research ,long non-coding RNA ,medicine.diagnostic_test ,biology ,Cell growth ,Chemistry ,Molecular biology ,Retraction ,AOC4P ,030104 developmental biology ,medicine.anatomical_structure ,Oncology ,Apoptosis ,030220 oncology & carcinogenesis ,biology.protein - Abstract
Jin-Chen Hu,1,* QuanWang,2,* Li-Xin Jiang,1 Li Cai,3 Hui-Yuan Zhai,1 Zeng-Wu Yao,1 Meng-Lai Zhang,1 Ye Feng4 1Department of Gastrointestinal Surgery, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China; 2Department of Gastrointestinal and Anal Surgery, The First Hospital of Jilin University, Changchun, China; 3Department of Pathology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China; 4Department of Gastrointestinal Colorectal and Anal Surgery, China-Japan Union Hospital of Jilin University, Changchun, China *These authors contributed equally to this work Objective: In this research, we explored the effect of long non-coding RNA (lncRNA) AOC4P on gastrointestinal stromal tumor (GIST) cells. Materials and methods: The expression of lncRNA AOC4P in tissues was detected by real-time PCR (RT-PCR). The epithelial–mesenchymal transition (EMT)-related proteins in tissues were analyzed by Western blot. The experiment included negative control group (CN), silence AOC4P group (si AOC4P), and silence negative control group (si CT). RT-PCR, MTT, Scratch, Transwell, and Annexin V-FITC methods were used to detect the expression of lncRNA AOC4P, cell proliferation, cell migration ability, cell invasion ability, and apoptosis, respectively. The EMT-related proteins including TGF-β, ZEB1, Vimentin, Snail, and E-cadherin were analyzed by Western blot. Results: The expression of lncRNA AOC4P and the expression of EMT-related proteins in high-risk GISTs were higher than that in low- and intermediate-risk GISTs (P
- Published
- 2018
4. Fisetin attenuates gastric mucosal lesions through modulating nuclear factor-kappa B and peroxisome proliferator-activated receptor-γ in rats
- Author
-
Li Cai, Baohong Hu, Lixin Jiang, Yifei Zhang, Zhenbin Zhang, Meng-Lai Zhang, Jinchen Hu, and Zeng-Wu Yao
- Subjects
chemistry.chemical_classification ,Chemistry ,Pharmaceutical Science ,Interleukin ,Peroxisome proliferator-activated receptor ,Pharmacology ,chemistry.chemical_compound ,medicine.anatomical_structure ,Mechanism of action ,Drug Discovery ,medicine ,Gastric mucosa ,Tumor necrosis factor alpha ,medicine.symptom ,Receptor ,Omeprazole ,Fisetin ,medicine.drug - Abstract
Background: Nowadays, the use of plant extracts is increasing in the world for the prevention and treatment of ulcer. Objective: The objective of this study was to explore the underlying mechanism of action of fisetin on ethanol-induced gastric ulcer model. Materials and Methods: In this study, gastric mucosal lesions were induced by ethanol in rats. Five groups of rats were formed based on the treatment administered: model group (model), omeprazole (40 mg/kg) group (omeprazole), high-dose fisetin group (100 mg/kg, H-fisetin), medium-dose fisetin group (50 mg/kg, M-fisetin), and low-dose fisetin group (25 mg/kg, L-fisetin). Interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α levels were assessed in serum. The expression of peroxisome proliferator-activated receptor (PPAR)-γ, nuclear factor-kappa B (NF-κB), and p38-mitogen-activated protein kinase (p38-MAPK) in the gastric mucosa was also measured. Results: In the case of the high-dose fisetin group, the level of TNF-α, IL-1β, and IL-6 decreased from 9.57 pg/mL to 5.19 pg/mL, from 0.59 pg/mL to 0.27 pg/mL, and from 37.96 pg/mL to 21.09 pg/mL, respectively. In the case of the omeprazole group, the level of TNF-α, IL-1β, and IL-6 decreased to 4.38 pg/mL, 0.27 pg/mL, and 18.58 pg/mL, respectively. The expression of PPAR-γ protein in the high-dose fisetin and omeprazole groups was about 1.5 times higher than that in the model group. Compared with the model group, the expression of NF-κB protein reduced to 0.34 level and 0.47 level in the omeprazole and high-dose fisetin groups, respectively. Compared with the model group, the expression of p38-MAPK protein reduced to 0.55 level and 0.68 level in the omeprazole and high-dose fisetin groups, respectively. Conclusion: Fisetin might relieve the symptoms of ethanol-induced gastric ulcer in rats through the regulation of NF-κB pathway.
- Published
- 2020
- Full Text
- View/download PDF
5. Comparison of lymph node number and prognosis in gastric cancer patients with perigastric lymph nodes retrieved by surgeons and pathologists
- Author
-
Dawei Zhao, Lixin Jiang, Yifei Zhang, Dong Wang, Jinchen Hu, Xixun Wang, Zhenbin Zhang, Hui-Yuan Zhai, and Zeng-Wu Yao
- Subjects
Cancer Research ,medicine.medical_specialty ,Stage ii ,03 medical and health sciences ,0302 clinical medicine ,lymph node retrieval ,Perigastric lymph node ,medicine ,Stage (cooking) ,Lymph node ,Survival analysis ,business.industry ,Cancer ,Perigastric ,medicine.disease ,Surgery ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,030211 gastroenterology & hepatology ,Original Article ,Lymph ,prognosis ,business ,Gastric cancer ,surgeon and pathologist - Abstract
OBJECTIVE To compare the numbers of positive and total lymph nodes and prognosis in gastric cancer patients whose perigastric lymph node retrieval was performed by surgeons and pathologists. METHODS We conducted a retrospective analysis of clinical and follow-up data from 1, 056 patients who underwent gastric cancer D2 radical lymph node resection between January 2008 and December 2010 in the Gastrointestinal Surgery Department of Yantai Yuhuangding Hospital. The follow-up ended in December 2015. Patients were divided into two groups according to the specialty of physicians who performed the postoperative perigastric lymph node retrieval: the surgeon group (475 cases) and the pathologist group (581 cases). The numbers of positive and total perigastric lymph nodes and the 3- and 5-year survival were compared between gastric cancer patients in the two groups overall and stratified by TNM stage (the 7th Edition of the American Joint Committee on Cancer). RESULTS Overall, the numbers of positive and total lymph nodes were significantly higher in the surgeon group than in the pathologist group (6.53±4.07 vs. 4.09±3.70, P=0.021; 29.64±11.50 vs. 20.71±8.56, P
- Published
- 2016
6. Dehydrocostus lactone inhibits gastrinoma cancer cell growth through apoptosis induction, sub-G1 cell cycle arrest, DNA damage and loss of mitochondrial membrane potential.
- Author
-
Hou-yong Long, Qing-xian Huang, Yong-yang Yu, Zhen-bin Zhang, Zeng-wu Yao, Hong-bing Chen, Jun-wei Feng, Long, Hou-Yong, Huang, Qing-Xian, Yu, Yong-Yang, Zhang, Zhen-Bin, Yao, Zeng-Wu, Chen, Hong-Bing, and Feng, Jun-Wei
- Subjects
CANCER cell growth ,CELL cycle ,MITOCHONDRIAL membranes ,MEMBRANE potential ,CELL survival ,ONTOGENY ,DNA damage - Abstract
Introduction: The purpose of the present study was to evaluate the antiproliferative activity of dehydrocostus lactone against human BON-1 cancer cell lines and to explore the possible underlying mechanism.Material and Methods: MTT cell viability assay was used to determine cytotoxic effects of dehydrocostus lactone in BON-1 cells. Fluorescence and transmission electron microscopic (TEM) techniques were used to study the effect of the compound on cellular morphology and apoptosis. Flow cytometry was used to assess the effect on cell cycle phase distribution. Effects of the drug on cell apoptosis and mitochondrial membrane potential were analyzed by flow cytometry using annexin v and rhodamine-123 as fluorescent probes.Results: The results of the present study indicated that dehydrocostus lactone significantly (p < 0.01) inhibited the growth of BON-1 cancer cells. These growth inhibitory effects of dehydrocostus lactone on BON-1 were found to be time and concentration-dependent. The IC50 of dehydrocostus lactone were found to be 71.9 μM and 52.3 μM at 24 and 48 h time intervals respectively. The growth inhibitory effects of dehydrocostus lactone were found to be due to loss of mitochondrial membrane potential, the induction of apoptosis and sub-G1 cell cycle arrest.Conclusions: Dehydrocostus inhibits in vitro gastrinoma cancer cell growth and therefore may prove beneficial in the management of gastrinoma cancer. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
7. [Progress of research in the relationship between microorganisms and colorectal cancer]
- Author
-
Zeng-wu, Yao and Yan-bing, Zhou
- Subjects
Inflammation ,Herpesvirus 4, Human ,Helicobacter pylori ,Humans ,Colorectal Neoplasms ,Papillomaviridae ,Helicobacter Infections - Abstract
Colorectal cancer is a common carcinoma of gastrointestinal tract, and its incidence is associated with genetic mutations, environment as well as inflammation. Recent studies have shown that many microorganisms may have played an important role in pathogenesis of colorectal cancer. The common bacteria involved in colorectal cancer are Streptococcus bovis, Helicobacter pylori, Escherichia coli, Bacteroides, and Fusobacterium, etc. The common viruses are Polyomavirus, Epstein Barr virus, Cytomegalovirus and Human papillomavirus, etc. The detailed mechanism of these microorganisms in the pathogenesis of colorectal cancer is unclear, and there are no reports on specific pathogenic microorganisms which cause the disease directly. The direction of future researches will focus on metagenome, metatranscriptome, and metaproteome of microorganisms associated with the incidence of colorectal cancer.
- Published
- 2013
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.